Good news for more than 2 million diabetes sufferers. Insulin injections could be a thing of the past in less than a year reports Diabetes UK, as inhaled insulin is set to become a reality for more than 700, 000 people using insulin every day in the UK alone.
UK welcomes the news that the US Food and Drug Administration (FDA) advisory committee has recommended approval of the inhaled insulin Exubera, which does away with painful injections.
This is especially good news for parents with diabetic children, who have to endure the struggle when administrating painful injections every day.
Both UK and US trials into the use of Exubera insulin for adults with Type 1 and Type 2 diabetes have already shown it works with no serious side effects. However some concern has been expressed about the long-tem effect of the drug and its manufacturers, Pfizer, Sanofi Aventis and Nektar Therapeutics are now conducting trials to check there are no side affects in the long run.
Although Inhaled insulin is not yet licensed for use, applications have been made with the European Medicines Evaluation Agency . If Exubera does get the go ahead then it will be an answer to many peoples prayers.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…